Before treatment of thyrotoxicosis has started it is not possible at present to foretell which patients will experience a protracted illness and which will promptly recover. The aim of assessment during treatment of thyrotoxicosis is to define which course the disease is running and consequently whether antithyroid drugs or destructive therapy will be the more appropriate.
Basis of Plan of Management
Destructive therapy for thyrotoxicosis frequently results in hypothyroidism, necessitating life-long treatment with thyroxine. Antithyroid drug therapy is followed by remission in a considerable proportion of patients and subsequent clinical hypothyroidism is rare. There thus seems to be a strong case for the use of antithyroid drugs as the initial treatment in most thyrotoxic patients under the age of45 years. Beyond the age of 45 or 50 years the risk of cardiac problems increases.
The plan of treatment proposed is an interim one based on data obtained in a prospective study of 105 patients followed for more than four years (Alexander, McLarty, Horton, and Pharmakiotis, 1973 We suggest, therefore, the use of antithyroid drugs in the majority of patients with Graves' disease under 45 years of age, coupled with repeated assessment of the response to treatment at sixmonthly intervals (Alexander et al, 1973; Goolden, Williams, and Thalassinos, 1973 In the interim plan described below the choice of the form of destructive therapy (surgery or radioiodine) is assumed to follow conventional lines (Wayne, 1960; McGirr, 1972 (FIG 2) Change to destructive therapy if the 20-minute 132I uptake has risen,2 is above 30%,3 or has not suppressed by 50% of the control value4.
Continue with antithyroid drugs for a further six months if the 20-minute 1321 uptake has fallen by more than 50%5 of the control value, or is less than 8 %. (Alexander et al, 1973) will require to be tested. Since also the normal radioiodine uptake may vary in different parts of the world and even within the same region (Stanbury, 1969; Pittman, Dailey, and Beschi, 1969) 
